In October 2023, I made a personal investment in the Fundrise Innovation Fund and continued adding to the position over the following two years. Earlier this year, the fund completed its public listing on the NYSE under the ticker VCX (NYSE:VCX), and my shares were recently distributed into my personal brokerage account following the lockup expiry.
I treated this allocation as an experiment. As an institutional venture investor managing family capital at GEX Ventures, I wanted to experience firsthand how retail venture products actually function from onboarding to public liquidity.
VCX succeeded in solving a genuine problem by providing everyday investors with direct access to top-tier private tech companies. However, the experience also highlighted important structural lessons about the difference between fundamental portfolio value and wrapper-driven market premiums.
What VCX Built and Why It Matters
Private tech companies have been staying private significantly longer over the past decade. By the time many category-defining companies reach public markets, much of their growth has already compounded behind closed doors. For retail investors, accessing these companies before an IPO has historically been almost impossible.
VCX created a direct mechanism to bridge that gap. According to the fund’s recent regulatory filings, its portfolio holds significant positions across several major private technology companies:
Anthropic PBC (over 20% of net assets)
OpenAI Group PBC (10% to 20%)
Databricks (10% to 20%)
SpaceX (2% to 5%)
Anduril Industries (2% to 5%)
Ramp Business Corp. (2% to 5%)
Flock Safety (2% to 5%)
Fluidstack (2% to 5%)
Epic Games (2% to 5%)
Building access to these names in the institutional private market typically requires years of relationship development, substantial minimum checks, or specialized SPV allocations. VCX packaged these holdings into a single vehicle accessible with low minimums.
For the broader venture ecosystem, that is a positive and legitimate innovation. Similar offerings in this category include AngelList USVC, ARK Venture Fund (ARKVX), Destiny Tech100 (DXYZ), and Robinhood Ventures.
Why It Remained a Personal Test
Despite the high quality of the portfolio, this investment remained a personal experiment and was not included in our formal investment strategy at GEX Ventures.
Our institutional mandate focuses on underwriting emerging managers and participating in concentrated co-investments where we have high-conviction access. A closed-end fund of late-stage assets assembled without direct relationships serves a completely different function:
Exposure versus selection: A public venture vehicle offers broad exposure to late-stage names rather than early alpha driven by manager selection.
Entry valuations: Late-stage secondary purchases enter companies after significant valuation markups have already occurred.
Fee structures: Public venture vehicles often have ongoing management fees around 1.85% to 2.0% plus administrative operating expenses, which can total over 3% annually without the hurdle rate protections common in private funds.
Testing the product personally allowed me to observe its mechanics without compromising our institutional portfolio parameters.
Understanding the Numbers: Paper Gain vs. NAV
Tracking this position through its listing and subsequent trading offered a clear case study in how public market pricing interacts with private assets.
At its peak post-listing market price, my position registered an unrealized multiple of roughly 45x on paper. Today, as trading has normalized and restricted shares have entered the market, the holding sits at just under 3x with an annualized internal rate of return around 70%.
These swings were not driven by changes within the underlying portfolio companies. Instead, they reflect the mechanics of public closed-end funds:
Net Asset Value baseline: The fund’s filed schedule of investments as of June 30, 2026, reported total net assets of approximately $777 million, representing a NAV of $21.70 per share.
Market premium dynamics: When trading began with a limited float, public retail demand drove the share price to a steep premium over NAV.
Convergence: As more shares became unlocked and freely tradable, the market price began drifting back closer toward its underlying asset value.
My realized performance was strong largely because I subscribed early at net asset value before public market enthusiasm created that temporary premium. Investors who purchased shares on the open market during the price spike bought into the sentiment premium rather than the fundamental valuation of the underlying companies.
The Takeaway for Expanding Retail Private Markets
With the SEC currently evaluating new frameworks to expand retail access to private market funds, products like VCX represent the early wave of a major market transition.
Democratizing access to private technology companies is a worthwhile objective that broadens wealth creation opportunities. However, as more retail venture vehicles enter the market, investors need to evaluate them with practical discipline:
Always verify the underlying holdings: Check the fund’s most recent regulatory filings to determine the holdings quality and net asset value per share.
Calculate the price-to-NAV ratio: Understand whether you are buying portfolio assets at fair value or paying a premium for the convenience of the wrapper.
Distinguish liquidity from valuation: Daily stock ticker liquidity does not eliminate the illiquid nature or long-term risk profile of early-stage private assets.
VCX demonstrated that retail venture access is technically and operationally feasible. The next step for investors is building the analytical habits needed to participate in these products intelligently.
This is an educational post about GEX Ventures investments. It is for informational purposes only and may not be relied on as legal, tax, securities or investment advice and does not constitute an offer to buy or sell interest in any products offered by us or others. Email me at mk@gex.vc or leave a comment if you’d like to exchange ideas.